Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome

Journal of Medical Investigation

Volumn 55, Issue 3-4, 2008, Pages 292-296

  Sasakawa, Atsushi ^a   Yamamoto, Yoshihiko ^a   Yajima, Keishiro ^a   Sakai, Mio ^a   Uehira, Tomoko ^a   Shirasaka, Takuma ^a   Makie, Toshio ^a,b  

^a OSAKA NATIONAL HOSPITAL   (Japan)

^b Office of New Drug IV Pharmaceuticals and Medical Divices Agency   (Japan)

Author keywords

AIDS related opportunistic infections; Cryptococcus; Immune reconstitution syndrome (IRS); Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIRETROVIRUS AGENT; BACTERIAL ANTIGEN; EFAVIRENZ; EMTRICITABINE; FLUCONAZOLE; FLUCYTOSINE; INDIAN INK; STEROID; TENOFOVIR; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN EDEMA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID PRESSURE; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCAL MENINGOENCEPHALITIS; CRYPTOCOCCUS; DIPLOPIA; DROWSINESS; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FEMALE; FEVER; HEADACHE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; LYMPH NODE BIOPSY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; STAINING; THROMBOCYTOPENIA;

EID: 56749164544     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: 10.2152/jmi.55.292     Document Type: Article

References (23)

1. Sepkowitz KA: AIDS--the first 20 years. N Engl J Med 344(23): 1764-1772, 2001
2. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW: Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. AIDS 13: 1687-1695, 1999
3. Dromer F, Mathoulin-Pelissier S, Fontanet A, Ronin O, Dupont B, Lortholary O: Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS 18(3): 555-562, 2004
4. Del Valle L, Pina-Oviedo S: HIV disorders of the brain: pathology and pathogenesis. Front Biosci 11: 718-732, 2006
5. Collazos J: Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs 17(12): 869-887, 2003
6. Corbett EL, Churchyard GJ, Charalambos S, Samb B, Moloi V, Clayton TC, Grant AD, Murray J, Hayes RJ, De Cock KM: Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin Infect Dis 34(9): 1251-1258, 2002
7. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE: Treatment of cryptococcal meningoencephalitis associated with the acquired immunodeficiency syndrome. N Engl J Med 337(1): 15-21, 1997
8. Shelburne SA 3rd, Darcourt J, White AC Jr, Greenberg SB, Hamill RJ, Atmar RL, Visnegarwala F: The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis 40(7): 1049 -1052, 2005
9. Woods ML II, MacGinley R, Eisen DP, Allworth AM: HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12: 1491-1494, 1998
10. DeSimone JA, Pomerantz RJ, Babinchak TJ : Inflammatory reactions in HIV-1- infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133: 447-454, 2000
11. Lipman M, Breen R: Immune reconstruction inflammatory syndrome in HIV. Curr Opin Infect Dis 19: 20-25, 2006
12. Skiest DJ, Hester LJ, Hardy RD: Cryptococcal immune IRIS: report of four cases in three patients and review of the literature. J Infect 51(5): e289-297, 2005
13. Broom J, Woods M II, Allworth A: Immune reconstitution inflammatory syndrome producing atypical presentations of cryptococcal meningoencephalitis: case report and a review of immune reconstitution-associated cryptococcal infections. Scand J Infect Dis 38(3): 219-221, 2006
14. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F: Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19(10): 1043-1049, 2005
15. Lieberman J, Shankar P, Manjunath N, Andersson J: Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98(6): 1667-1677, 2001
16. Shibuya K, Hirata A, Omuta J, Sugamata M, Katori S, Saito N, Murata N, Morita A, Takahashi K, Hasegawa C, Mitsuda A, Hatori T, Nonaka H: Granuloma and cryptococcosis. J Infect Chemother 11(3): 115-122, 2005
17. X Bai, J-D Chen, A-G Yang, F Torti, S-Y Chen: Genetic co-inactivation of macrophage-and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines. Nature 5 (7): 984-994, 1998
18. Adler-Moore J, Proffitt RT: Effect of tissue penetration on AmBisome efficacy. Curr Opin Invest Drugs 4(2): 179-185, 2003
19. Takemoto K, Yamamoto Y, Ueda Y: Influence of the progression of cryptococcal meningitis on brain penetration and efficacy of AmBisome in a murine model. Chemotherapy 52(6): 271-278, 2006
20. Deray G: Amphotericin B nephrotoxicity. J Antimicrob Chemother 49 (Suppl. 1): 37-41, 2002
21. Adler-Moore JP, Chiang SM, Satorius A, Guerra D, McAndrews B, McManus EJ, Proffitt RT: Treatment of murine candidosis and cryptococcosis with a unilamellar liposomal amphotericin B formulation (AmBisome). J Antimicrob Chemother 28 (Suppl. B): 63-71, 1991
22. Takemoto K, Yamamoto Y, Ueda Y, Sumita Y, Yoshida K, Niki Y: Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis. J Antimicrob Chemother 57(4): 724-731, 2006
23. Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A: Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67(3): 383-388, 2006